Health
Rapid CD169 assay for COVID-19 screening – News-Medical.Net
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory…
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The assay detects the upregulation of whole blood monocyte CD169, which has been reported as a marker of viral infections.
This rapid assay was more sensitive than the currently used method and less likely to produce false-negative results, especially among early and asymptomatic patients.
…
-
Noosa News22 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business22 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News22 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News14 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder